New use of cyclolignans and new cyclolignans

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 493/04 (2006.01) A61K 31/34 (2006.01) A61K 31/36 (2006.01) A61K 31/365 (2006.01) A61P 5/06 (2006.01) A61P 9/10 (2006.01) A61P 17/06 (2006.01) A61P 35/00 (2006.01) C07D 317/48 (2006.01) C07D 317/54 (2006.01) C07D 317/70 (2006.01)

Patent

CA 2455328

The invention refers to new compounds and the use thereof as well as the use of known cyclolignans having a trans configuration of the lactone ring as inhibitors of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, especially cancer. Especially deoxypodophyllotoxin can be used for treatment of leukemia in humans.

L'invention concerne de nouveaux composés et leur utilisation, ainsi que l'utilisation de cyclolignans connus présentant une position trans du noyau de lactone comme inhibiteurs du récepteur du facteur-1 de croissance semblable à l'insuline. Lesdits composés peuvent servir dans le traitement de maladies dépendant d'IGF-1R, notamment les cancers. En particulier, on peut utiliser la déoxypodo-phyllotoxine dans le traitement de la leucémie chez les humains.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

New use of cyclolignans and new cyclolignans does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New use of cyclolignans and new cyclolignans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New use of cyclolignans and new cyclolignans will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1711437

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.